High cholesterol is one of the most common findings on a routine blood test, and one of the least understood. The label comes from a single line on a lab report, yet the number people focus on is often not the one that matters most. In this article you will learn how to read every line of a lipid panel, why non-HDL cholesterol and apolipoprotein B often describe risk better than LDL alone, whether fasting is required, when lipoprotein(a) is worth measuring, and how US clinicians decide who benefits from treatment. You will also get a straight answer about symptoms, the inherited form, and the treatments that work.
What high cholesterol actually means
Cholesterol is a waxy fat your liver makes and your body needs for cell membranes, hormones and vitamin absorption. It does not dissolve in blood, so it travels inside protein-wrapped carriers called lipoproteins, and those carriers are the real story. Low-density lipoproteins deliver cholesterol to tissues and can lodge in artery walls; high-density lipoproteins carry it back.
Having high cholesterol means too many artery-damaging particles circulate for too long. Over years some slip into the artery wall, trigger inflammation and build plaque, a process called atherosclerosis that causes heart attacks, most strokes and peripheral artery disease. On paperwork you may see the terms hypercholesterolemia, or dyslipidemia when several values are off at once.
Two points matter. The damage is cumulative, reflecting a lifetime of particle burden rather than this month. And cholesterol never acts alone: it interacts with blood pressure, blood sugar, smoking and kidney function, which is why lipid results are read inside a wider picture.
Reading your lipid panel line by line
When a doctor says your cholesterol is high, they are reading a standard lipid panel. Most panels report four values; better panels add two or three more.
| Line on your report | What it actually measures | How it is judged in the United States |
|---|---|---|
| Total cholesterol | All cholesterol carried by every particle | About 150 mg/dL is described as optimal |
| LDL cholesterol (LDL-C) | Cholesterol inside low-density lipoproteins, the plaque-forming particles | About 100 mg/dL or below; much lower after a heart attack |
| HDL cholesterol (HDL-C) | Cholesterol inside high-density lipoproteins, returned to the liver | At least 40 mg/dL in men, 50 mg/dL in women |
| Triglycerides | Blood fat, sensitive to meals, alcohol and blood sugar | Below 150 mg/dL |
| Non-HDL cholesterol | Total cholesterol minus HDL: every artery-damaging particle at once | Usually about 30 mg/dL above your LDL goal |
| Apolipoprotein B (apoB) | The number of artery-damaging particles, since each carries one apoB protein | Read against your overall risk, not one universal cutoff |
| Lipoprotein(a), or Lp(a) | An inherited particle that adds risk independently of LDL | One lifetime measurement is usually enough |
Why non-HDL cholesterol is often the better number
Non-HDL cholesterol is total cholesterol minus HDL, which leaves everything harmful in one figure: LDL, very-low-density lipoproteins, remnant particles and Lp(a). It costs nothing extra, appears on almost every report and needs no fasting sample. When triglycerides run high it captures risk that LDL alone quietly misses, so many clinicians read it before they read the LDL cholesterol line.
Apolipoprotein B, and what it adds
LDL cholesterol says how much cholesterol sits inside the particles; apoB says how many particles there are. Each carries one apoB protein, so the count tracks how many objects can enter an artery wall, and two people with identical LDL can differ widely. Readers who want the full picture review their apolipoprotein B result, and some laboratories also report apolipoprotein A1.
Lipoprotein(a) and the case for measuring it once
Lp(a) is an LDL-like particle with an extra protein attached. Its level is set almost entirely by genetics, stays stable through adult life and moves very little with diet, exercise or statins, while independently raising the risk of heart attack, stroke and calcific aortic valve narrowing. Because it does not drift, several US and international lipid societies recommend checking it once in adulthood. A dedicated guide explains the lipoprotein(a) result.
HDL, total cholesterol and triglycerides in context
HDL was once called good cholesterol, but very high levels add no protection and drugs that only raise it have not reduced events, so a separate article treats the HDL cholesterol figure as a risk marker rather than a target. Total cholesterol mixes helpful and harmful particles, which is why doctors rarely act on it alone. Triglycerides react quickly to food, alcohol and untreated diabetes, so one high reading deserves a repeat, as the article covering triglyceride results explains.
Fasting, calculated LDL, and the numbers that trip people up
Do you need to fast?
Usually not. For a first screening in an adult not already on lipid-lowering medication, a non-fasting sample is acceptable and is now the default in many US practices: eating raises triglycerides modestly and leaves total cholesterol, HDL and non-HDL essentially unchanged. Fasting for 8 to 12 hours is still requested when triglycerides came back very high, or when the visit includes a fasting glucose test.
Calculated LDL versus directly measured LDL
Most laboratories do not measure LDL cholesterol at all. They calculate it, traditionally by subtracting HDL and a fifth of the triglyceride value from total cholesterol. That shortcut, the Friedewald equation, becomes unreliable when triglycerides exceed roughly 400 mg/dL and when LDL itself is low, where it underestimates. Newer formulas such as Martin-Hopkins and the NIH equation correct much of that error, and some laboratories run a direct LDL assay. This is a main reason non-HDL cholesterol and apoB have gained ground: neither depends on an estimate.
US reports use milligrams per deciliter (mg/dL) while most of Europe uses millimoles per liter (mmol/L). Values also drift a few percent between draws, so a single borderline result is a reason to retest rather than a diagnosis.
Why there is no single target number
People want one figure that means safe. US practice does not work that way: cholesterol is one input into an estimate of overall cardiovascular risk, and treatment intensity follows that estimate.
American clinicians long used the pooled cohort equations for ten-year risk. The American Heart Association has since released the PREVENT equations, which estimate risk of heart disease, stroke and heart failure from age 30 across ten and thirty years, add kidney function, and can include long-term blood sugar control. The consequence is that the same LDL number leads to different advice in two people.
What pushes toward medication includes established artery disease, diabetes, poorly controlled blood pressure, chronic kidney disease, smoking, a very high LDL alone, a raised Lp(a) and a family history of early heart attacks. Age counts too, since a thirty-year-old and a seventy-year-old with identical numbers face different lifetime exposure. Readers juggling several of these often read the guide covering high blood pressure. Many go on to the guide covering type 2 diabetes.
The honest answer about symptoms
High cholesterol produces no symptoms. No headache, no fatigue and no ache in the legs reliably signals it, and online lists of warning signs describe either advanced artery disease or unrelated conditions. The position is stated plainly by the Centers for Disease Control and Prevention: a blood test is the only way to know. That is why screening exists, and why most people first learn their numbers during an unrelated check-up.
What eventually appears is the consequence of untreated plaque: chest pressure on exertion, breathlessness, cramping calf pain when walking, or the sudden symptoms of a heart attack or stroke. Those are signs of established disease, not of the cholesterol level, and the same arterial strain contributes to the condition described in the guide covering heart failure.
Familial hypercholesterolemia and its visible signs
Familial hypercholesterolemia is the exception. It affects roughly one adult in 250, impairs the liver receptor that clears LDL and keeps LDL high from birth, so arteries accumulate decades of extra exposure. It remains widely undiagnosed, and unlike ordinary high cholesterol it can leave physical marks:
- Tendon xanthomas: firm, painless thickening of the Achilles tendon or the knuckle tendons.
- Xanthelasma: soft yellowish deposits on or around the eyelids.
- Corneal arcus: a pale grey ring at the edge of the iris, meaningful only before about age 45.
Suspect it when untreated LDL is very high, or when close relatives had heart attacks in their forties or fifties. Diagnosis is clinical and can be confirmed genetically, and it changes the plan for the whole family: each first-degree relative has a one-in-two chance of carrying it.
What causes high cholesterol
Most cases result from an inherited tendency amplified by daily habits: genetics set the range, and the rest decides where inside it you land.
- Diets rich in saturated fat, refined starch and alcohol.
- Excess body weight, especially abdominal, which raises triglycerides and lowers HDL.
- Physical inactivity, smoking and heavy alcohol use.
- Insulin resistance and type 2 diabetes, which change particle size and number more than LDL cholesterol.
- An underactive thyroid, a correctable cause examined in the guide covering hypothyroidism symptoms and treatments.
- Kidney, liver and nephrotic disease.
- Medications including some diuretics, corticosteroids, immunosuppressants and retinoids.
- Pregnancy and menopause, which shift lipid levels hormonally.
Because thyroid and blood sugar problems are treatable, a first abnormal lipid panel often prompts a thyroid test and a glycated hemoglobin test.
Treatments that lower cholesterol
What lifestyle honestly achieves
Lifestyle change is the foundation and deserves honest weighting. Replacing saturated fat with unsaturated fat, eating more soluble fiber from oats, beans, barley and fruit, adding plant sterols, exercising and stopping smoking typically lower LDL by roughly five to fifteen percent, while also improving blood pressure, blood sugar and triglycerides. What lifestyle rarely does is normalize a genetically high LDL or move Lp(a). Habits set your baseline, and medication closes whatever gap remains.
Statins, muscle symptoms and monitoring
Statins slow cholesterol production in the liver, prompting liver cells to pull more LDL from the blood. They are the best-studied cardiovascular drugs available and reduce heart attacks and strokes in proportion to how far they lower LDL. Doses are described as moderate or high intensity rather than by milligrams.
Muscle symptoms are the reason most people stop. Blinded studies in which people alternated between statin and dummy tablets without knowing which was which found most aching and weakness appeared just as often on the dummy tablet. That does not mean the discomfort is imagined; it means the statin is often not the cause, and most people who retry at a lower dose or with a different statin tolerate it. When symptoms are severe doctors check the creatine kinase level.
Monitoring is lighter than many expect. A liver panel is checked before starting, but routine repeat liver and muscle enzyme testing is not recommended without symptoms, though doctors may recheck liver enzymes if problems appear. A repeat lipid panel four to twelve weeks after a change confirms the response, then annually.
What comes after a statin
| Treatment | How it works | How it is taken | Typical role |
|---|---|---|---|
| Ezetimibe | Blocks cholesterol absorption in the small intestine | Daily tablet | Added when a statin alone falls short |
| Bempedoic acid | Blocks an enzyme upstream of the statin target, active in the liver | Daily tablet | Option for people who cannot tolerate statins |
| PCSK9 inhibitors (alirocumab, evolocumab) | Antibodies protecting the liver receptor that clears LDL | Injection every two to four weeks | High risk, or LDL still high on oral therapy |
| Inclisiran | A small interfering RNA quieting the PCSK9 pathway | Injection about twice a year | Alternative to PCSK9 antibodies, chosen for convenience |
| Lipoprotein apheresis | Filters lipoproteins out of the blood | Clinic procedure every one to two weeks | Reserved for severe inherited forms |
Ezetimibe adds roughly another fifth of LDL lowering on top of a statin. Bempedoic acid is activated by an enzyme present in the liver but not in muscle, which is why it causes fewer muscle complaints, though it can raise uric acid. PCSK9 antibodies and inclisiran roughly halve LDL again on top of oral treatment. Fibrates and prescription omega-3 target very high triglycerides rather than LDL, and drugs aimed specifically at Lp(a) remain in late-stage trials.
When to see a doctor
Book an appointment rather than waiting for a routine visit if any of these applies:
- Your LDL cholesterol is 190 mg/dL or higher on a repeat test, which warrants assessment for an inherited cause.
- A parent or sibling had a heart attack, stroke or stent before 55 in men or 65 in women.
- You notice Achilles or knuckle tendon thickening, yellowish eyelid deposits, or a grey corneal ring before your mid-forties.
- Your triglycerides exceed 500 mg/dL, which risks pancreatitis.
- You develop chest pressure on exertion, unusual breathlessness, or calf pain when walking that eases at rest.
- You have started a statin and have muscle symptoms that are persistent or severe, or come with dark urine.
Call emergency services immediately for sudden chest pain, one-sided weakness, facial droop or slurred speech.
Latest scientific advances
Lipid research has moved quickly in the last three years, toward counting particles rather than measuring cholesterol.
ApoB describes risk more accurately than LDL
A 2025 systematic review, a study pooling every trial and cohort that meets agreed quality rules, compared the three markers across roughly 600,000 people; whenever apoB and LDL disagreed, apoB matched what actually happened. A second 2025 review found many people with type 2 diabetes or metabolic syndrome reach a reassuring LDL number while apoB and non-HDL stay elevated, because their particles are smaller and more numerous. What this means for you: with diabetes or insulin resistance, LDL alone can understate risk, and non-HDL costs nothing to read.
Only some drugs move lipoprotein(a)
A 2025 pooled analysis of 147 randomized trials covering more than 145,000 participants sorted out which treatments change Lp(a). Statins, ezetimibe, bempedoic acid, fibrates and omega-3 do not shift it; PCSK9 antibodies and inclisiran lower it by roughly a fifth to a third. What this means for you: a good LDL response to a statin says nothing about your Lp(a), one more reason to measure it once.
An oral option that works for statin-intolerant people
A randomized trial published in 2023 followed nearly 14,000 statin-intolerant adults for over three years. Bempedoic acid lowered LDL and reduced the combined rate of heart attacks, strokes, cardiovascular death and artery procedures compared with a dummy tablet. What this means for you: being unable to take a statin no longer means having no proven option.
A gentler statin dose plus ezetimibe can match a high dose
A 2025 analysis combining individual records from two randomized trials in people with established artery disease compared a high-intensity statin against a moderate dose paired with ezetimibe. Outcomes over three years were comparable, with fewer discontinuations in the combination group. What this means for you: if a high statin dose is uncomfortable, a combination may reach the same place.
Twice-yearly injections work in inherited high cholesterol
A 2025 pooled analysis of 23 randomized trials in adults and children with familial hypercholesterolemia found PCSK9 antibodies and inclisiran cut LDL by roughly half on top of standard treatment and also lowered apoB and Lp(a), with side effects similar to comparison groups. What this means for you: inherited high cholesterol that resists tablets now has effective answers.
This is evidence about groups, not instructions for one person, and some of it is still preliminary. Use it to ask better questions.
Glossary
| Term | Definition |
|---|---|
| Lipoprotein | A protein-wrapped package that carries cholesterol and fat through the blood, since neither dissolves in water. |
| LDL cholesterol (LDL-C) | Cholesterol carried by low-density lipoproteins, the particles that deposit cholesterol in artery walls. |
| Non-HDL cholesterol | Total cholesterol minus HDL cholesterol. It sums all the cholesterol carried by artery-damaging particles. |
| Apolipoprotein B (apoB) | A protein found once on every artery-damaging particle, so measuring it counts the particles themselves. |
| Lipoprotein(a), Lp(a) | An inherited LDL-like particle that adds cardiovascular risk on its own and changes little with lifestyle or statins. |
| Atherosclerosis | The gradual buildup of fatty plaque inside artery walls that narrows or blocks blood flow. |
| Familial hypercholesterolemia | An inherited condition in which the liver clears LDL poorly, producing very high cholesterol from birth. |
| Friedewald equation | The traditional formula laboratories use to estimate LDL cholesterol instead of measuring it directly. |
| Statin | A tablet that reduces cholesterol production in the liver and prompts the liver to remove more LDL from the blood. |
| PCSK9 | A protein that destroys the liver receptor for LDL. Blocking it lets the liver clear more LDL from the blood. |
Frequently asked questions
What are the warning signs of high cholesterol?
There are none in the ordinary sense. High cholesterol does not cause fatigue, headaches, tingling or any other everyday sensation, and articles listing ten warning signs are describing either advanced artery disease or unrelated conditions. The exceptions are the physical deposits seen in the inherited form: thickened Achilles or knuckle tendons, yellowish eyelid patches, and a grey ring around the iris appearing before middle age. Everything else requires a blood test. If you have not had your lipids checked in the last five years, that is the single most useful step.
My cholesterol is 250. Is that high?
A total cholesterol of 250 mg/dL is above the level generally considered optimal, but on its own it does not tell you what to do. The answer depends on how that 250 splits between LDL, HDL and triglycerides, on your non-HDL figure, and on the rest of your risk profile: age, blood pressure, blood sugar, smoking status, kidney function and family history. A person of 30 with high HDL and no other risk factors and a person of 65 with diabetes may receive completely different advice from the same number. Bring the full panel to the conversation, not just the headline.
Are there signs of high cholesterol on the face?
Only in specific circumstances. Xanthelasma, the soft yellowish plaques that form on or near the eyelids, can accompany high cholesterol, although many people who have them show normal lipid levels. Corneal arcus, a pale grey ring at the outer edge of the iris, is common and meaningless after about age 60 but does suggest an inherited lipid disorder when it appears before 45. Neither finding is a substitute for testing, and neither rules high cholesterol out. Ordinary high cholesterol leaves the face completely unchanged.
Is high cholesterol reversible?
Levels are certainly modifiable, and in many people diet, weight loss, exercise and stopping smoking bring them back into a comfortable range, especially where a treatable cause such as an underactive thyroid or untreated diabetes was driving the numbers. Whether the arterial plaque already formed reverses is a different question: intensive lipid lowering can stabilize and modestly shrink plaque, but the realistic goal is to halt progression. Inherited forms are controllable rather than reversible, and treatment for them is generally lifelong.
What causes high cholesterol in an otherwise healthy person?
Genetics is the usual answer. Lean, active people with good diets can carry inherited variants that raise LDL or Lp(a), and familial hypercholesterolemia is far more common than most people assume. Other explanations worth excluding are an underactive thyroid, undiagnosed kidney or liver disease, pregnancy, menopause, and medications such as corticosteroids, some diuretics and certain immunosuppressants. A sudden jump in previously stable numbers usually has a cause worth investigating rather than a lifestyle explanation.
How often should adults have their cholesterol checked?
Most guidance suggests a first check in young adulthood, with repeat testing about every five years for adults at low risk. Testing becomes more frequent, often every one to two years, for men from about 45 and women from about 55, and annually after 65. Children are usually screened once between ages 9 and 11 and again in the late teens, earlier when there is a family history of early heart disease. Anyone taking lipid-lowering medication is retested more often, first a few weeks after a change and then yearly.
Sources
- Centers for Disease Control and Prevention – About Cholesterol – CDC, 2024 – cdc.gov
- MedlinePlus, National Library of Medicine – Cholesterol – National Institutes of Health, 2024 – medlineplus.gov
- Mayo Clinic – High cholesterol: symptoms and causes – Mayo Foundation for Medical Education and Research, 2023 – mayoclinic.org
- Sehayek D, Cole J, Bjornson E, et al. – ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk – Journal of Clinical Lipidology, 2025 – doi.org/10.1016/j.jacl.2025.05.024
- Witt C, Renfroe LG, Lyons TS – Discordance between serum cholesterol concentration and atherogenic lipoprotein particle number in people with metabolic disease: a systematic review – Diabetes, Obesity and Metabolism, 2025 – doi.org/10.1111/dom.16335
- Xie S, Galimberti F, Olmastroni E, et al. – Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials – Atherosclerosis, 2025 – doi.org/10.1016/j.atherosclerosis.2025.120420
- Nissen SE, Lincoff AM, Brennan D, et al. – Bempedoic acid and cardiovascular outcomes in statin-intolerant patients – New England Journal of Medicine, 2023 – doi.org/10.1056/NEJMoa2215024
- Lee YJ, Hong SJ, Kang WC, et al. – Alternative LDL cholesterol-lowering strategy versus high-intensity statins in atherosclerotic cardiovascular disease: a systematic review and individual patient data meta-analysis – JAMA Cardiology, 2025 – doi.org/10.1001/jamacardio.2024.3911
- Ho VQT, Tran NB, Nguyen N, et al. – PCSK9 targeting therapies for familial hypercholesterolaemia: a meta-analysis of efficacy on lipid biomarkers and safety in adults and children across 23 RCTs – Open Heart, 2025 – doi.org/10.1136/openhrt-2025-003490
Further reading
- Total cholesterol: understanding your levels
- Apolipoprotein A1: understanding your levels
- Alanine aminotransferase: understanding your levels
- CRP: understanding your blood test results
- Chronic kidney disease: symptoms, causes and treatments
Understand your lab results with BloodSense
A cholesterol result only makes sense next to the rest of your panel. BloodSense reads your report in context and explains what your total cholesterol, LDL, HDL, triglycerides and non-HDL figures mean together, in plain language, along with related tests such as blood sugar and thyroid function. It helps you understand your results and prepare better questions for your appointment. It does not diagnose, and it does not replace your doctor.
